KRISTINA ENCALADA: Open Payments
NPI 1578286142 · HOLLYWOOD, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$964 in 55 payments from 15 companies in 2025. Trend: 2023 $1,344 · 2024 $1,900 · 2025 $964
Food & beverage: $964
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 7 | $174 |
| ABBVIE INC. | 17 | $166 |
| Axsome Therapeutics, Inc. | 3 | $89 |
| E.R. Squibb & Sons, L.L.C. | 4 | $86 |
| Neurocrine BioSciences, Inc. | 3 | $75 |
| Otsuka America Pharmaceutical, Inc. | 4 | $73 |
| Corium, LLC | 5 | $51 |
| Janssen Pharmaceuticals, Inc | 2 | $48 |
| Braeburn Inc. | 2 | $46 |
| Lundbeck LLC | 2 | $45 |
Products named: VRAYLAR, HETLIOZ, Auvelity, COBENFY, FANAPT, INGREZZA, REXULTI, Azstarys.
Industry payments across FL — which companies pay providers there.
